Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/101737
Full metadata record
DC FieldValueLanguage
dc.creatorRui Adao
dc.creatorDiana Santos Ribeiro
dc.creatorMiriam T Rademaker
dc.creatorAdelino F Leite Moreira
dc.creatorCarmen Bras Silva
dc.date.accessioned2022-09-08T09:15:19Z-
dc.date.available2022-09-08T09:15:19Z-
dc.date.issued2015
dc.identifier.issn1359-6446
dc.identifier.othersigarra:107267
dc.identifier.urihttps://hdl.handle.net/10216/101737-
dc.description.abstractUrocortin (Ucn)-2 - corticotropin-releasing hormone receptor 2 signaling has favorable effects in the cardiovascular system, including coronary vasodilatation, with increased coronary blood flow and conductance and augmented cardiac contractility and output, as well as protection against ischemia/reperfusion injury. Indeed, several animal studies have confirmed the salutary therapeutic effects of Ucn-2 in chronic heart failure, with improvements in cardiac performance and animal survival. In addition, recent clinical trials have demonstrated the benefits of Ucn-2 in patients with stable chronic heart failure on optimal medical therapy.
dc.language.isoeng
dc.rightsrestrictedAccess
dc.subjectMedicina básica
dc.subjectBasic medicine
dc.titleUrocortin 2 in cardiovascular health and disease
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Ciências da Nutrição e Alimentação
dc.identifier.doi10.1016/j.drudis.2015.02.012
dc.identifier.authenticusP-00G-J1Q
dc.subject.fosCiências médicas e da saúde::Medicina básica
dc.subject.fosMedical and Health sciences::Basic medicine
Appears in Collections:FCNAUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
107267.pdf
  Restricted Access
1.56 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.